Serum Institute of India

Serum Institute To Manufacture Sputnik Vaccine From September

New Delhi: The Pune-based Serum Institute of India (SII) will start manufacturing the anti-COVID vaccine Sputnik V from September, Russian…

July 13, 2021

Serum Institute Of India Applies For Study Trial Of Novavax Vaccine

Pune: India's premier vaccine manufacturer, Serum Institute of India (SII), has sought permission from Drugs Controller General of India (DCGI)…

January 29, 2021

Fire Losses Pegged At Over Rs 1,000 Crore: Adar Poonawalla

Pune: Serum Institute of India (SII) confirmed that it suffered losses to the tune of Rs 1,000 crore in Thursday’s…

January 23, 2021

Serum Institute Fire To Affect Production Of BCG & Rotavirus Vaccines

Pune: The fire at Serum Institute of India (SII) that killed five workers on Thursday won’t result in any loss…

January 22, 2021

Serum Institute Fire Doused, But 5 Workers Lose Lives

Pune: Five persons lost their lives after a fire broke out at an under-construction site in Serum Institute of India’s…

January 21, 2021

COVID Vaccine To Cost 5 Times More For Pvt Players: Serum CEO

Pune: The CEO of Serum Institute of India (SII), Adar Poonawalla, on Tuesday said his firm has decided to sell…

January 12, 2021

Govt Panel Okays Oxford Vaccine In India, DCGI To Take Final Call On Rollout

New Delhi: A day ahead of the scheduled dry run for vaccination in all the states, a government-appointed panel of…

January 1, 2021

Rs 80,000 Cr Needed In 2021 For COVID Vaccine Distribution In India, Says SII

New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one…

December 19, 2020

Serum Institute, Bharat Biotech Vaccines Not Cleared Yet, More Data Sought

New Delhi: Serum Institute of India (SII) and Bharat Biotech have not been granted emergency use authorisation of their coronavirus…

December 9, 2020

COVID-19 Vaccine: Serum Institute Seeks Emergency Use Approval

New Delhi: The Serum Institute of India (SII) has sought emergency use authorisation of its vaccine candidate Covishield in the…

December 7, 2020